Numinus Wellness Inc.

TSXV: NUMI, OTC: LKYSD

Company Overview

Numinus Wellness Inc. is an operating company at the forefront of addressing the growing prevalence of mental health issues and the desire for greater wellness.

The company's operations include Numinus Bioscience, a testing and research facility that can leverage the emerging market of psychedelic therapies to address mental illness, addictions and PTSD; Numinus Wellness, a treatment and healing centre model we aim to scale globally; and Numinus R&D, which is creating partnerships with leading research groups to advance practice and understanding in the space.

Sustainable cannabis revenue through Numinus Bioscience's laboratory and production operations will help fund our growth plans.

Management Team

Mr. Payton Nyquvest
Pres, CEO & Chairman

Mr. John Fong
CFO & Corp. Sec.

Mr. Michael Tan
COO & Director

Mr. Kraig Docherty
Chief People Officer

Ms. Stacey Wallin
Chief Strategy Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Key Highlights

Market Capitalization
$30,275,326

Shares Outstanding
93,726,800